Flucinar 15g.

Drug
Fluocinolon acetonide 0.25 mg / 1 g of
Excipients
Propylene glycol, citric acid, ethyl alcohol 96%, metilhdroksibenzoat,
propilbhidroksibenzoat, carbopol 940, triethanolamine, disodium edetate, purified water to 1 g.

Properties and action
Fluocinolone acetonide is a synthetic glucocorticosteroids for topical administration. It has lipophilic properties. Exhibits lasting anti-inflammatory and anti-allergic effects are much stronger than those of hydrocortisone. It can easily pass through the skin and accumulate in and corneal layer. It may find it even 15 days after topical application. It has systemic action.
Fluocinolone acetonide is processed by the liver. Collected by the urine in small amounts of unchanged or in the form of the glucuronide conjugates. Fluocinolone acetonide absorption is enhanced when applied to the face or on irritated, sensitive or damaged skin epidermis and in covering dressing. The extent of systemic absorption of fluocinolone acetonide through the skin in children is higher than for adults.

Evidence
Unresponsive to other steroids:
• psoriasis, especially scalp
• Seborrheic dermatitis, especially on the scalp
• Flat red lichen
• prurigo
• Eczema

Contraindications
• Do not use in bacterial, viral and fungal skin infections, especially acne, rosacea, dermatitis iperioralen.
• Do not apply after vaccination in case of hypersensitivity to product ingredients.

Adverse reactions
Possible acne, steroid induced purpura, suppressing the growth of the epidermis, atrophy of subcutaneous tissues, dry skin, hirsutism or alopecia, depigmentation of skin, skin atrophy, striae, telangiectasis, perioral dermatitis, folliculitis, secondary infections. In some cases it is possible urticaria and maculopapular rash, it is possible excitation of existing damage. After administration in covering bandage product may be absorbed and cause chronic effects, including edema, hypertension, decreased immunity. After application to the skin of the eyelids may develop glaucoma or cataracts.

Interactions
None known.

Dosage and method of administration
• Flucinar is intended for topical use. It applies only on prescription only under recommended by the doctor diseases. Do not use bandage covering without specific indication.
• Accurately applied a small amount of product on the affected area of the skin, not more often than 1-2 times and not more than 2 g of the gel for 24 hours.
• It is recommended that treatment might take longer than 2-3 weeks. On the face can not apply more than 1 week.
• Do not use in children under 2 years of age.
In children over 2 years to be used with caution once daily on small skin areas.

Special warnings and special precautions for use
• During prolonged application on a large skin surface is possible weakening of immunity, the occurrence of edema and hypertension.
• In case of infections on the site of application of the gel to take appropriate antibacterial or antifungal treatment.
• If signs of infection reduced implementation of Flucinar to break up and mastering.
• The product should be applied carefully on the eyelids in patients with glaucoma or cataracts.
• Apply gently on the face
• To be used with caution in existing atrophy of the subcutaneous tissue.
• The product contains parabens, which can cause urticaria. Usually these are delayed reactions, eg. contact dermatitis. Rarely cause sensitization reactions of immediate-type urticaria and bronchospasm.

• Flucinar gel is topically applied in the first phase of the treatment of acute and severe infected dermatoses dry flowing with svrahvrogovyavane which respond to steroids (before ointment). Well applied to the hairy skin and in patients sensitive to ointment and cream. The gel allows to cover a larger area of skin treated with a small amount of product.
• patient to notify any adverse reactions occurring during use of the product.

Pregnancy and lactation
Pregnancy
Flucinar may be used in pregnant women only for a short period on small areas of the skin, only in cases where the benefits outweigh the risks. Do not apply in the first three months of pregnancy. Safety for use during pregnancy: Category C
Breastfeeding
Careful application of Flucinar in nursing mothers for short periods on small skin areas, but not on the chest.

Effects on ability to drive and use machines
Not harm psychomotor functions, the ability to drive and use machines.

Expiry date
3 years

Special storage conditions
Store below 25 0 C. Do not freeze.
Keep out of reach of children.